March 12, 2009
$46.8 billion: Basel-based Roche acquires rest of SF's Genentech.
GENEVA (March 12)--Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn’t already own, ending a long corporate struggle with its U.S.-based cancer drug partner. [more]
Posted by JD Hull at March 12, 2009 11:59 PM
Post a comment
Thanks for signing in, . Now you can comment. (sign out)(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)